April 2021

In the next issue of Pharma Technology Focus, we dive into the online world of social media marketing to learn how pharma companies are adapting to the growing prominence of digital platforms. Plus, we take a look at recent collaborations between Big Pharma and Big Tech and what pooling resources from two powerhouse industries could mean for the future of medicine.

Elsewhere, as vaccines indicate a light at the end of the Covid-19 tunnel we turn our attention to the next pandemic to find out how we can avoid healthcare disasters in the future, examine changing attitudes to chronic fatigue care, and investigate a new regulatory framework for the production, distribution, and export of medical cannabis on the Isle of Man.

Also, we examine the transformative potential of mRNA-based vaccines, speaks to the minds behind the Ineos Oxford Institute for AMR Research, and learn how pharma companies have been embracing the public benefit corporation model.


Editor | Eloise McLennan

Commissioning Editor | Daniel Garrun

Writers | Allie Nawrat, Natalie Healey, Abi Millar, Chloe Kent, Peter Kohut
Magazine Designer | Marzia Del Gaone

Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Filipe Costa, Martina Labaiova
Lead Designer | John Hammond 

Publisher | Susanne Hauner
Digital Publishing Director | Duncan West


Sales Manager | Nimai Amin

+44 (0) 207 936 6453

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.